Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Psykey, Inc.

CEOSPNK
Healthcare
Medical - Instruments & Supplies
$0.003
$0.00(0.00%)
U.S. Market opens in 1h 37m

Psykey, Inc. Fundamental Analysis

Psykey, Inc. (CEOS) shows moderate financial fundamentals with a PE ratio of -2.38, profit margin of -5.58%, and ROE of 39.67%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE39.67%
Cash Position272.58%
PEG Ratio-0.02

Areas of Concern

Operating Margin-5.10%
Current Ratio0.56
We analyze CEOS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 63.2/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
63.2/100

We analyze CEOS's fundamental strength across five key dimensions:

Efficiency Score

Weak

CEOS struggles to generate sufficient returns from assets.

ROA > 10%
-8.51%

Valuation Score

Excellent

CEOS trades at attractive valuation levels.

PE < 25
-2.38
PEG Ratio < 2
-0.02

Growth Score

Weak

CEOS faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

CEOS shows balanced financial health with some risks.

Debt/Equity < 1
-1.20
Current Ratio > 1
0.56

Profitability Score

Moderate

CEOS maintains healthy but balanced margins.

ROE > 15%
39.67%
Net Margin ≥ 15%
-5.58%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CEOS Expensive or Cheap?

P/E Ratio

CEOS trades at -2.38 times earnings. This suggests potential undervaluation.

-2.38

PEG Ratio

When adjusting for growth, CEOS's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values Psykey, Inc. at -0.82 times its book value. This may indicate undervaluation.

-0.82

EV/EBITDA

Enterprise value stands at -3.65 times EBITDA. This is generally considered low.

-3.65

How Well Does CEOS Make Money?

Net Profit Margin

For every $100 in sales, Psykey, Inc. keeps $-5.58 as profit after all expenses.

-5.58%

Operating Margin

Core operations generate -5.10 in profit for every $100 in revenue, before interest and taxes.

-5.10%

ROE

Management delivers $39.67 in profit for every $100 of shareholder equity.

39.67%

ROA

Psykey, Inc. generates $-8.51 in profit for every $100 in assets, demonstrating efficient asset deployment.

-8.51%

Following the Money - Real Cash Generation

Operating Cash Flow

Psykey, Inc. generates strong operating cash flow of $91.70K, reflecting robust business health.

$91.70K

Free Cash Flow

Psykey, Inc. generates strong free cash flow of $88.31K, providing ample flexibility for dividends, buybacks, or growth.

$88.31K

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

CEOS converts 57.09% of its market value into free cash.

57.09%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.38

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.82

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.006

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.20

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.56

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.40

vs 25 benchmark

ROA

Return on assets percentage

-0.09

vs 25 benchmark

ROCE

Return on capital employed

1.49

vs 25 benchmark

How CEOS Stacks Against Its Sector Peers

MetricCEOS ValueSector AveragePerformance
P/E Ratio-2.3828.25 Better (Cheaper)
ROE39.67%780.00% Weak
Net Margin-5.58%-20122.00% (disorted) Weak
Debt/Equity-1.200.30 Strong (Low Leverage)
Current Ratio0.564.66 Weak Liquidity
ROA-8.51%-14687.00% (disorted) Weak

CEOS outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Psykey, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ